European Equities Traded in the US Rise in Thursday Trading

MT Newswires Live08-13 23:14

European equities traded in the US as American depositary receipts were higher late Thursday morning, rising 0.45% to 1,969.72 on the S&P Europe Select ADR Index.

From continental Europe, the gainers were led by biopharmaceutical company Cellectis (CLLS) and biotech firm Evaxion (EVAX), which rose 4.9% and 2.9% respectively. They were followed by telecommunications company Nokia (NOK) and healthcare tech company Royal Philips (PHG), which increased 2.8% and 1.9% respectively.

The decliners from continental Europe were led by Ascendis Pharma (ASND) and petroleum refiner Equinor (EQNR), which fell 3.8% and 2.8% respectively. They were followed by oil and gas company Eni (E) and pharmaceutical company Novo Nordisk (NVO), which were down 1.8% and 0.7% respectively.

The gainers from the UK were led by Autolus Therapeutics (AUTL) and Silence Therapeutics (SLN), which rose 4.7% and 3.6% respectively. They were followed by software firm Endava (DAVA) and British American Tobacco (BTI), which were up 3.3% and 2.9% respectively.

The decliners from the UK and Ireland were led by Trinity Biotech (TRIB) and Mereo BioPharma Group (MREO), which lost 3% and 2.5% respectively. They were followed by mining firm BHP (BHP) and oil and gas company BP (BP), which fell 1.8% and 1.5% respectively.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment